Heart transplant (HT) recipients have an increased risk of experiencing severe complications if infected with COVID-19, according to new findings published in JAMA Cardiology.

What is the best way to determine—and improve—the quality of a PCI program?

Newer-generation drug-eluting stents (n-DES) are a more effective option for the percutaneous treatment of small-vessel coronary disease (SVCD) than drug-coated balloons (DCBs), according to new findings published in JACC: Cardiovascular Interventions.

Women are at an increased risk of adverse events following percutaneous coronary intervention (PCI), according to new findings published in the Journal of the American College of Cardiology.

Heart bypass patients experience better outcomes when the surgeon uses a segment of the radial artery instead of one from the saphenous vein, according to a new analysis of more than 1,000 patients.   

As many as 700 hearts from donors with hepatitis C are discarded each year in the U.S. New research suggests at least some of these organs may be suitable for transplant.